Founded in 1999, Nanjing Lifenergy R&D Co., Ltd. (Lifenergy) is holded by the first listed domestic pharmaceutical business company (Nanjing Pharmaceutical Co., Ltd.) in China. As a high-tech enterprise, Lifenergy is committed to research , manufacturing and marketing of high quality APIs and formulations mainly focusing on the field of nephrology as well as other areas.
Lifenergy, the leader of R&D in pharmaceutical industry of China, has successfully developed over 30 new drugs, which have gained multiple foundations granted by city, province as well as state. On the basis of plentiful product resources, technology development and service, Lifenergy effectively promote the industrial convergence and transformation, focus on specialized technology-based market development work based on core products, create a new situation in global markets while establishing the first domestic brand specialty products.
With built-in GLP-certificated and fully-equipped modern laboratory, we have state-of-the-art scientific research background. As a people-oriented company, we train and build our talent, with renowned advising experts. Our employees are all of Bachelor degree, more than 35% have Master's degree. Post-doctoral workstations, effective human resources, technology resources give rise to a powerful competitive advantage of the company.
In the near future, the company will closely focus on globalization strategies, stick to technology-based approach to establish the concept of globalization of R & D, and cultivate a group of high-tech products which represent the specialized technology of this company, and gradually construct the specialized technology based high-tech platform. We adhere to the high-quality & professional academic promotion philosophy, adhere to the business concept of technical driven trade, set up the thought of “close to the terminal, understand the terminal, serve the terminal ” , pursuit the constant innovation of promotion model and business model. Ultimately Lifenergy would become a high technology-based international business enterprise.